206 related articles for article (PubMed ID: 35523613)
1. Fibroepithelial lesions of the breast: A review of recurring diagnostic issues.
Seow DYB; Tay TKY; Tan PH
Semin Diagn Pathol; 2022 Sep; 39(5):333-343. PubMed ID: 35523613
[TBL] [Abstract][Full Text] [Related]
2. Fibroepithelial tumours of the breast-a review.
Lerwill MF; Lee AHS; Tan PH
Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
[TBL] [Abstract][Full Text] [Related]
3. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
4. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
Li JJX; Tse GM
Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
[TBL] [Abstract][Full Text] [Related]
5. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
[TBL] [Abstract][Full Text] [Related]
6. Fibroepithelial lesions revisited: implications for diagnosis and management.
Tan PH
Mod Pathol; 2021 Jan; 34(Suppl 1):15-37. PubMed ID: 32461622
[TBL] [Abstract][Full Text] [Related]
7. Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised?
Lee A; James J; Whisker L; Rakha EA; Ellis IO
Ann R Coll Surg Engl; 2022 May; 104(5):361-366. PubMed ID: 34939848
[TBL] [Abstract][Full Text] [Related]
8. Development of a Management Algorithm for the Diagnosis of Cellular Fibroepithelial Lesions From Core Needle Biopsies.
Jung J; Kang E; Chae SM; Kim H; Park SY; Yun B; Kim SM; Jang M; Kim SW; Kim EK
Int J Surg Pathol; 2018 Dec; 26(8):684-692. PubMed ID: 29774785
[TBL] [Abstract][Full Text] [Related]
9. Phyllodes tumours of the breast: a consensus review.
Tan BY; Acs G; Apple SK; Badve S; Bleiweiss IJ; Brogi E; Calvo JP; Dabbs DJ; Ellis IO; Eusebi V; Farshid G; Fox SB; Ichihara S; Lakhani SR; Rakha EA; Reis-Filho JS; Richardson AL; Sahin A; Schmitt FC; Schnitt SJ; Siziopikou KP; Soares FA; Tse GM; Vincent-Salomon A; Tan PH
Histopathology; 2016 Jan; 68(1):5-21. PubMed ID: 26768026
[TBL] [Abstract][Full Text] [Related]
10. A Diagnostic Approach to Fibroepithelial Breast Lesions.
Tan BY; Tan PH
Surg Pathol Clin; 2018 Mar; 11(1):17-42. PubMed ID: 29413655
[TBL] [Abstract][Full Text] [Related]
11. Cytological Criteria to Distinguish Phyllodes Tumour of the Breast from Fibroadenoma.
Maritz RM; Michelow PM
Acta Cytol; 2017; 61(6):418-424. PubMed ID: 28738381
[TBL] [Abstract][Full Text] [Related]
12. A study of fibroepithelial tumours of the breast.
Badhe BA; Iyengar KR; Alva N
Indian J Cancer; 2002; 39(3):91-6. PubMed ID: 12928563
[TBL] [Abstract][Full Text] [Related]
13. Paediatric fibroepithelial lesions revisited: pathological insights.
Tay TK; Chang KT; Thike AA; Tan PH
J Clin Pathol; 2015 Aug; 68(8):633-41. PubMed ID: 25998513
[TBL] [Abstract][Full Text] [Related]
14. Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis.
Pfarr N; Kriegsmann M; Sinn P; Klauschen F; Endris V; Herpel E; Muckenhuber A; Jesinghaus M; Klosterhalfen B; Penzel R; Lennerz JK; Weichert W; Stenzinger A
Genes Chromosomes Cancer; 2015 Jul; 54(7):444-52. PubMed ID: 25931199
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic stromal histomorphology in fibroepithelial breast lesions: a fresh perspective.
Aiyer HM; Jain M; Thomas S; Logani KB
Indian J Pathol Microbiol; 2000 Jan; 43(1):5-12. PubMed ID: 12583412
[TBL] [Abstract][Full Text] [Related]
16. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.
Lawton TJ; Acs G; Argani P; Farshid G; Gilcrease M; Goldstein N; Koerner F; Rowe JJ; Sanders M; Shah SS; Reynolds C
Int J Surg Pathol; 2014 Dec; 22(8):695-8. PubMed ID: 25161205
[TBL] [Abstract][Full Text] [Related]
17. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
Silverman JS; Tamsen A
Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
[TBL] [Abstract][Full Text] [Related]
18. Frequent MED12 mutations in phyllodes tumours of the breast.
Yoshida M; Sekine S; Ogawa R; Yoshida H; Maeshima A; Kanai Y; Kinoshita T; Ochiai A
Br J Cancer; 2015 May; 112(10):1703-8. PubMed ID: 25839987
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesis.
Lien HC; Huang CS; Yang YW; Jeng YM
Histopathology; 2016 Feb; 68(3):433-41. PubMed ID: 26109290
[TBL] [Abstract][Full Text] [Related]
20. Precise diagnosis of breast phyllodes tumors using Raman spectroscopy: Biochemical fingerprint, tumor metabolism and possible mechanism.
Wu Y; Wang Y; He C; Wang Y; Ma J; Lin Y; Zhou L; Xu S; Ye Y; Yin W; Ye J; Lu J
Anal Chim Acta; 2023 Dec; 1283():341897. PubMed ID: 37977771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
